Subsequent studies revealed numerous additional mutations that activate NOTCH1 in T-ALL, resulting in both ligand-independent and ligand-dependent gain-of-function alleles, which are collectively present in the majority (>60%) of T-ALL patient samples72. Here, NOTCH1 is linked to acute lymphoblastic leukemia.